1
|
Adler M, Allmendinger A. Filling Unit Operation for Biological Drug Products: Challenges and Considerations. J Pharm Sci 2024; 113:332-344. [PMID: 37992868 DOI: 10.1016/j.xphs.2023.11.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2023] [Revised: 11/15/2023] [Accepted: 11/15/2023] [Indexed: 11/24/2023]
Abstract
One of the key unit operations during the aseptic fill-finish process of parenteral products, such as biologics, is the filling process of the formulated, sterile filtered drug substance into primary packaging containers. The applied filling technology as well as the process performance majorly impacts final drug product quality. The present review provides an overview of commonly used filling technologies during fill-finish operations of biologics including positive displacement pump systems such as radial peristaltic pump, rotary piston pump, rolling diaphragm pump, or innovative systems such as the linear peristaltic pump, as well as time-over-pressure filling technology. The article describes the operating principle of each pump system and reviews advantages and drawbacks. We highlight specific considerations for individual systems, such as the risk of protein particle formation and particle shedding from wear and tear of tubing, and discuss current literature about general challenges associated with the filling process, such as hydrogen peroxide uptake, adsorption phenomena to tubing material, and needle clogging. We suggest process development and process characterization studies to assess the impact of the filling process on product quality, and lastly provide an outlook about the use of disposable equipment during filling operations related to sustainability considerations.
Collapse
Affiliation(s)
- Michael Adler
- ten23 health AG, Mattenstr. 22, 4058 Basel, Switzerland
| | - Andrea Allmendinger
- ten23 health AG, Mattenstr. 22, 4058 Basel, Switzerland; Institute of Pharmaceutical Sciences, Department of Pharmaceutics, University of Freiburg, Sonnenstr. 5, 79104 Freiburg, Germany.
| |
Collapse
|
2
|
Painchart L, Odou P, Bussières JF. [Comparative profile of the use of filter needles in Quebec and France in healthcare facility]. Ann Pharm Fr 2017; 76:71-77. [PMID: 29145996 DOI: 10.1016/j.pharma.2017.09.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2017] [Revised: 08/11/2017] [Accepted: 09/20/2017] [Indexed: 10/18/2022]
Abstract
OBJECTIVES The manipulation of drugs from glass ampules can generate particles when the ampule is broken. Several authors recommend the use of filter needle to withdraw the drug content. The main objective is to establish an inventory of the use of filter needles and the perception of pharmacists in Quebec and in France. METHODS This is a cross-sectional descriptive study. A questionnaire was sent to all health facilities in Quebec (n=30) and a selection of hospitals in France (n=100). Respondents were asked to answer a questionnaire that included policies and procedures on the use of these medical devices and the conditions of their use at the pharmacy and in healthcare services. RESULTS In total, 27 respondents from Quebec (response rate: 90%) and 41 respondents from France (response rate: 41%) participated in our survey. In Quebec, all exploitable questionnaires except one (42/43) used five micron filter needles at the pharmacy against 28% of utilisation in healthcare services. In France, this practice is nearly ignored. CONCLUSIONS Action should be taken to decide on the use of filter needles including studies to confirm the consequences of the presence of these particles on an animal model, discussions with regulatory authorities to clarify the situation, incentives for manufacturers to use vials.
Collapse
Affiliation(s)
- L Painchart
- Unité de recherche en pratique pharmaceutique, département de pharmacie, CHU Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, H3T1C5 Montréal, Québec, Canada
| | - P Odou
- EA 7365, groupe de recherche sur les formes injectables et les technologies associées (GRITA), université de Lille, CHU de Lille, 59000 Lille, France
| | - J-F Bussières
- Unité de recherche en pratique pharmaceutique, département de pharmacie, CHU Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, H3T1C5 Montréal, Québec, Canada; Faculté de pharmacie, université de Montréal, Montréal, QC, Canada.
| |
Collapse
|
3
|
Al Salloum H, Saunier J, Dazzi A, Vigneron J, Etcheberry A, Marlière C, Aymes-Chodur C, Herry JM, Bernard M, Jubeli E, Yagoubi N. Characterization of the surface physico-chemistry of plasticized PVC used in blood bag and infusion tubing. Mater Sci Eng C Mater Biol Appl 2017; 75:317-334. [PMID: 28415468 DOI: 10.1016/j.msec.2017.02.057] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/26/2016] [Revised: 11/28/2016] [Accepted: 02/14/2017] [Indexed: 10/20/2022]
Abstract
Commercial infusion tubing and blood storage devices (tubing, blood and platelets bags) made of plasticized PVC were analyzed by spectroscopic, chromatographic and microscopic techniques in order to identify and quantify the additives added to the polymer (lubricants, thermal stabilizers, plasticizers) and to put into evidence their blooming onto the surface of the devices. For all the samples, deposits were observed on the surface but with different kinds of morphologies. Ethylene bis amide lubricant and metallic stearate stabilizers were implicated in the formation of these layers. In contact with aqueous media, these insoluble deposits were damaged, suggesting a possible particulate contamination of the infused solutions.
Collapse
Affiliation(s)
- H Al Salloum
- IFR 141, EA 401, UFR de Pharmacie, Univ. Paris Sud - Université Paris-Saclay, 92290 Chatenay Malabry, France
| | - J Saunier
- IFR 141, EA 401, UFR de Pharmacie, Univ. Paris Sud - Université Paris-Saclay, 92290 Chatenay Malabry, France.
| | - A Dazzi
- LCP, CNRS-UMR8000, Univ. Paris-Sud, Université Paris-Saclay, 91405 Orsay, France
| | - J Vigneron
- ILV, CNRS, UVSQ, Université Paris-Saclay, 45 Avenue des Etats Unis, 78035 Versailles, France
| | - A Etcheberry
- ILV, CNRS, UVSQ, Université Paris-Saclay, 45 Avenue des Etats Unis, 78035 Versailles, France
| | - C Marlière
- ISMO, UMR CNRS 8214, Univ. Paris Sud, Université Paris-Saclay, 91405 Orsay cedex, France
| | - C Aymes-Chodur
- IFR 141, EA 401, UFR de Pharmacie, Univ. Paris Sud - Université Paris-Saclay, 92290 Chatenay Malabry, France
| | - J M Herry
- Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, 78350 Jouy-en-Josas, France
| | - M Bernard
- IFR 141, EA 401, UFR de Pharmacie, Univ. Paris Sud - Université Paris-Saclay, 92290 Chatenay Malabry, France
| | - E Jubeli
- IFR 141, EA 401, UFR de Pharmacie, Univ. Paris Sud - Université Paris-Saclay, 92290 Chatenay Malabry, France
| | - N Yagoubi
- IFR 141, EA 401, UFR de Pharmacie, Univ. Paris Sud - Université Paris-Saclay, 92290 Chatenay Malabry, France
| |
Collapse
|